• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级执业提供者在卓越心包疾病中心的作用。

The Role of the Advanced Practice Provider in a Pericardial Center of Excellence.

作者信息

Heine Mary, Agrawal Ankit, Wensink Emma, Wang Tom Kai Ming, Klein Allan

机构信息

Cleveland Clinic, Cleveland, OH, USA.

Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Curr Cardiol Rep. 2025 Mar 10;27(1):69. doi: 10.1007/s11886-025-02205-y.

DOI:10.1007/s11886-025-02205-y
PMID:40063308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11893689/
Abstract

PURPOSE OF REVIEW

Pericarditis can be a chronic and complex disease requiring years of treatment. These patients require close monitoring of labs, medications and their side effects, as well as virtual and inpatient follow up. Due to the complexity of this disease, many of these patients are treated for months and sometimes years. Our review highlights the role Advanced practice providers (APP) play in managing the complexity of these patients by providing efficient and quality care.

RECENT FINDINGS

Multi-modality cardiac imaging is the cornerstone to the evaluation and treatment of pericardial diseases. The addition of Interleukin (IL-1) blockers or biologics (Rilonacept, Anakinra) in the last few years provides targeted therapy for these patients. Using imaging guided therapy (IGT) these complex patients require close, continuous follow up and monitoring as well as frequent medication titration. The outcomes for these pericardial patients are improved with these centers due to the specialized medical and surgical care. Advanced Practice Providers play a vital role in a pericardial center with ordering the appropriate imaging and labs, handling medication titration, and providing patient education and continuity of care for these patients. They have been shown to decrease mortality, increase quality of care, and increase medication adherence.

摘要

综述目的

心包炎可能是一种慢性复杂疾病,需要数年治疗。这些患者需要密切监测实验室检查结果、药物及其副作用,以及进行线上和住院随访。由于这种疾病的复杂性,许多患者需要接受数月甚至数年的治疗。我们的综述强调了高级执业提供者(APP)通过提供高效优质的护理在管理这些患者的复杂性方面所发挥的作用。

最新发现

多模态心脏成像技术是心包疾病评估和治疗的基石。在过去几年中,添加白细胞介素(IL-1)阻滞剂或生物制剂(利罗那肽、阿那白滞素)为这些患者提供了靶向治疗。对于这些复杂患者,采用影像引导治疗(IGT)需要密切、持续的随访和监测,以及频繁的药物滴定。由于专业的医疗和手术护理,这些心包疾病患者在这些中心的治疗效果得到改善。高级执业提供者在心包疾病中心发挥着至关重要的作用,他们负责安排适当的成像检查和实验室检查、处理药物滴定,并为这些患者提供患者教育和持续护理。事实证明,他们可以降低死亡率、提高护理质量并提高药物依从性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e058/11893689/4fd885824897/11886_2025_2205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e058/11893689/d21beb5cd6da/11886_2025_2205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e058/11893689/4fd885824897/11886_2025_2205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e058/11893689/d21beb5cd6da/11886_2025_2205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e058/11893689/4fd885824897/11886_2025_2205_Fig2_HTML.jpg

相似文献

1
The Role of the Advanced Practice Provider in a Pericardial Center of Excellence.高级执业提供者在卓越心包疾病中心的作用。
Curr Cardiol Rep. 2025 Mar 10;27(1):69. doi: 10.1007/s11886-025-02205-y.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging.心包疾病:多模态心脏成像新概念和新进展的国际立场声明。
JACC Cardiovasc Imaging. 2024 Aug;17(8):937-988. doi: 10.1016/j.jcmg.2024.04.010.
4
Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis.复发性心包炎的诊断和靶向治疗的范式转变。
Curr Cardiol Rep. 2023 Sep;25(9):993-1000. doi: 10.1007/s11886-023-01912-8. Epub 2023 Jul 17.
5
Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.用白细胞介素-1 阻断治疗 Erdheim-Chester 病中的心脏炎症。
Front Immunol. 2018 Jun 1;9:1233. doi: 10.3389/fimmu.2018.01233. eCollection 2018.
6
Management strategies in pericardial emergencies.心包急症的管理策略。
Herz. 2006 Dec;31(9):891-900. doi: 10.1007/s00059-006-2937-0.
7
8
Florida Controlled Substance Prescribing佛罗里达州受管制物质处方开具
9
Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis.急性和复发性心包炎的新型病理生理、诊断和治疗概念
Rev Cardiovasc Med. 2023 Mar 3;24(3):77. doi: 10.31083/j.rcm2403077. eCollection 2023 Mar.
10
Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors.复发性心包炎的新兴治疗方法:白细胞介素-1 抑制剂。
J Am Heart Assoc. 2021 Oct 5;10(19):e021685. doi: 10.1161/JAHA.121.021685. Epub 2021 Sep 25.

引用本文的文献

1
CT-Based Pericardial Composition Change as an Imaging Biomarker for Radiation-Induced Cardiotoxicity.基于CT的心包成分变化作为放射性心脏毒性的影像生物标志物
Cancers (Basel). 2025 Aug 13;17(16):2635. doi: 10.3390/cancers17162635.

本文引用的文献

1
Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review.心包炎的诊断、风险分层与治疗:综述
JAMA. 2024 Oct 1;332(13):1090-1100. doi: 10.1001/jama.2024.12935.
2
Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis.预测复发性心包炎患者的长期临床结局。
J Am Coll Cardiol. 2024 Sep 24;84(13):1193-1204. doi: 10.1016/j.jacc.2024.05.072. Epub 2024 Aug 31.
3
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging.心包疾病:多模态心脏成像新概念和新进展的国际立场声明。
JACC Cardiovasc Imaging. 2024 Aug;17(8):937-988. doi: 10.1016/j.jcmg.2024.04.010.
4
Pericardial Diseases and Best Practices for Pericardiectomy: JACC State-of-the-Art Review.心包疾病和心包切除术的最佳实践:JACC 最新综述。
J Am Coll Cardiol. 2024 Aug 6;84(6):561-580. doi: 10.1016/j.jacc.2024.05.048.
5
Quality of Life in Patients With Recurrent Pericarditis.复发性心包炎患者的生活质量
Can J Cardiol. 2024 Nov;40(11):2275-2278. doi: 10.1016/j.cjca.2024.05.018. Epub 2024 May 27.
6
How and Why to Set Up a Pericardial Disease Clinic.如何以及为何设立心包疾病诊所。
Can J Cardiol. 2023 Aug;39(8):1149-1151. doi: 10.1016/j.cjca.2023.04.028. Epub 2023 May 11.
7
The Role of Nurse Practitioners in the Management of Heart Failure Patients and Programs.护士从业者在心力衰竭患者管理和项目中的作用。
Curr Cardiol Rep. 2022 Dec;24(12):1945-1956. doi: 10.1007/s11886-022-01796-0. Epub 2022 Nov 25.
8
Complex Management Decisions in a Professional Athlete With Recurrent Pericarditis.一名复发性心包炎职业运动员的复杂管理决策
JACC Case Rep. 2022 Sep 7;4(17):1090-1093. doi: 10.1016/j.jaccas.2022.05.015.
9
Advances in Imaging and Targeted Therapies for Recurrent Pericarditis: A Review.影像学与靶向治疗复发性心包炎的进展:综述
JAMA Cardiol. 2022 Sep 1;7(9):975-985. doi: 10.1001/jamacardio.2022.2584.
10
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.白细胞介素-1受体拮抗剂rilonacept治疗复发性心包炎的3期试验
N Engl J Med. 2021 Jan 7;384(1):31-41. doi: 10.1056/NEJMoa2027892. Epub 2020 Nov 16.